Featured on BNN Bloomberg: Antibodies to be test-ready by July 1st: AbCellera CEO

“CEO of AbCellera Carl Hansen says that if human testing of his company’s antibodies is successful, AbCellera will be in a position to mass manufacture, scale up, and deliver antibodies to the broad population for preventative use against COVID-19 within months.”

Read full coverage on BNN Bloomberg.

PARTNERSHIP

Together we can make game-changing discoveries.